{
  "title": "M21-1, Part VIII, Subpart ii, Chapter 2, Section C - Rating Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177443/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-C-Rating-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nPresumptive Service Connection (SC) for Disabilities Associated With BPOT Exposure\n2\nDenying SC for Disabilities Associated With BPOT Exposure\n3\nAdditional Rating Considerations\n1\n.\nPresumptive SC for Disabilities Associated With BPOT Exposure\nIntroduction\nThis topic contains information about presumptive SC for disabilities associated with BPOT exposure, including\nestablishing SC for a qualifying presumptive disability\ndate disabilities became subject to presumptive SC based on BPOT exposure\npresumptive SC for asthma\nBPOT general rating decision requirements\n, and\nestablishing an effective date for qualifying disabilities due to BPOT exposure\n.\nChange Date\nJune 6, 2025\nVIII.ii.2.C.1.a\n.\nEstablishing SC for a Qualifying Presumptive Disability\nEstablish presumptive service connection (SC) due to fine particulate matter exposure if the evidence establishes\nservice in a qualifying location as described in\nM21-1, Part VIII, Subpart ii, 2.A.1.e\n, and\nthe Veteran has been diagnosed with a condition listed in\n38 U.S.C. 1120\n38 CFR 3.320a\n, or\n38 CFR 3.320b\n.\nImportant\n:\nPresumptive SC for the conditions listed in\n38 U.S.C. 1120\nbecame effective August 10, 2022, based on\nPublic Law 117-168\n, Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act of 2022.\nUnder current rules, the presumption of SC does not require the disability to manifest within any time frame after service nor to any degree of disability.\nPresumptive SC for cancer associated with exposure to burn pits and other toxins, including fine particulate matter (BPOT) may only be established if the cancer in consideration is the primary or originating site of the cancer.\nReferences\n:  For more information on\nthe history of BPOT exposure policies, see\nM21-1, Part VIII, Subpart ii, 2.A.1.a\nwhich diagnoses qualify as a presumptive under\n38 U.S.C. 1120\n, see\nVBA Letter 20-24-06, Updated Guidance on Processing Claims Involving PACT Act\n, and\nM21-1, Part VIII, Subpart ii, 2.A.1.f\npresumptive SC for metastatic cancer, see\nM21-1, Part V, Subpart ii, 2.B.1.b\n, and\npresumptive BPOT disabilities, see\nM21-1, Part VIII, Subpart ii, 2.A.1.f-h\n.\nVIII.ii.2.C.1.b\n.\nDate Disabilities Became Subject to Presumptive SC Based on BPOT Exposure\nThe table below shows the dates on which the BPOT disabilities became subject to presumptive SC.\nDisability\nEffective Date\nChronic respiratory illnesses:\nasthma\nrhinitis, and\nsinusitis, to include rhinosinusitis.\nImportant\n:\nUnder historical 38 CFR 3.320, these conditions were required to have manifested within 10 years of separation from a period of active duty.\nHistorical 38 CFR 3.320 was superseded by the PACT Act on August 10, 2022.\nAugust 5, 2021\nSpecific rare respiratory cancers:\nsquamous cell carcinoma (SCC) of the larynx\nSCC of the trachea\nadenocarcinoma of the trachea\nsalivary gland-type tumors of the trachea\nadenosquamous carcinoma of the lung\nlarge cell carcinoma of the lung\nsalivary gland-type tumors of the lung\nsarcomatoid carcinoma of the lung, and\ntypical and atypical carcinoid of the lung.\nImportant\n:  This historical provision in 38 CFR 3.320 was superseded by the PACT Act on August 10, 2022.\nApril 26, 2022\nDisabilities listed in\n38 U.S.C. 1120\n:\nhead cancer of any type\nneck cancer of any type\nrespiratory cancer of any type\ngastrointestinal cancer of any type\nreproductive cancer of any type\nlymphoma cancer of any type\nkidney cancer\nbrain cancer\nmelanoma\npancreatic cancer\nchronic bronchitis\nchronic obstructive pulmonary disease\nconstrictive bronchiolitis or obliterative bronchiolitis\nemphysema\ngranulomatous disease\ninterstitial lung disease\npleuritis\npulmonary fibrosis\nsarcoidosis\nglioblastoma\nasthma diagnosed after service\nchronic sinusitis, and\nchronic rhinitis.\nAugust 10, 2022\nUnder\n38 CFR 3.320a\n:\nurinary bladder cancer, including over-lapping sites of the bladder, and\nureter cancer, including the ureteric orifice, and urachus.\nJanuary 2, 2025\nUnder\n38 CFR 3.320b\n:\nacute leukemias\nchronic leukemias\nmultiple myelomas, including monoclonal gammopathy of undetermined significance\nmyelodysplastic syndromes, and\nmyelofibrosis.\nJanuary 10, 2025\nVIII.ii.2.C.1.c\n.\nPresumptive SC for Asthma\nThe PACT Act provided for presumptive SC for, “asthma that was diagnosed after service of the covered Veteran.”  This means the presumption only applies when asthma is diagnosed after service.  Asthma is also a presumptive condition presumed to be associated with exposure to fine particulate matter per\n38 CFR 3.320\n.\nThe Department of Veterans Affairs has implemented the PACT Act presumption for asthma as shown in the table below for all decisions made.\nIf asthma was first diagnosed …\nThen …\nprior to, or\nduring service\nSC must be considered under other theories of entitlement (i.e., direct, aggravation).\nafter service\nthe presumption of SC under\n38 CFR 3.320\nand\n38 U.S.C. 1120\napplies.\nVIII.ii.2.C.1.d\n.\nBPOT General Rating Decision Requirements\nIn order to properly document decisions based on BPOT exposure in Veterans Benefits Management System-Rating (VBMS-R), claims processors must use a combination of applicable system-generated language, analysis fragments, and glossary text fragments to adequately explain the basis of all decisions.\nIf awarding or denying a claim for presumptive SC based on BPOT exposure, apply the following guidelines:\ncite the applicable regulatory or statutory authority for the decision, when applicable\nlist favorable findings, if applicable, specific to the facts of the case, and\nassign the appropriate special issue and special issue basis to each decided issue.\nReferences\n:  For more information on\ncompleting the rating decision, see\nM21-1, Part V, Subpart iv, 1.A\n, and\nthe\nVBMS Rating User Guide\n, and\nhistorical rating requirements for particulate matter claims, see the attachment,\nHistorical_M21-1VIII_ii_2_SecC_5-4-22.docx.\nVIII.ii.2.C.1.e\n.\nEstablishing an Effective Date for Disabilities Due to BPOT Exposure\nWhen assigning an effective date, follow the guidance in\nM21-1, Part V, Subpart ii, 4.A\nrelevant to the facts of the claim.\nIn addition to the general principles governing the assignment of effective dates, consider the following relevant factors when awarding presumptive SC based on BPOT exposure:\nWhen did the disability become subject to presumptive SC?\nDid the Veteran’s service qualify under\n38 CFR 3.320\nor under a location added in\n38 U.S.C. 1119\n?\nDid the qualifying disability manifest within any applicable manifestation period?\nUse the table below when assigning an effective date based on presumptive BPOT SC requirements being met.\nIf the award involves a …\nAnd the condition …\nThen the effective date cannot be prior to\n…\ncurrent\n38 CFR 3.320(a)(2)\ncondition (sinusitis, rhinitis, or asthma), and\n38 CFR 3.320\nlocation\nmanifested outside the 10-year manifestation period\nAugust 10, 2022, the date the law was changed to allow for the award of benefits under\n38 U.S.C. 1120\n.\nmanifested within the 10-year manifestation period\nAugust 5, 2021, the date the regulation went into effect to allow for presumptive SC.\nhistorical 38 CFR 3.320(a)(3) condition (rare respiratory cancer), and\n38 CFR 3.320\nlocation\nN/A\nApril 26, 2022, the date the regulation went into effect to allow for presumptive SC.\nlocation added in\n38 U.S.C. 1119\n, or\npresumptive condition added by\n38 U.S.C. 1120\nN/A\nAugust 10, 2022, the date the law was changed to allow for the award of benefits under\n38 U.S.C. 1120\n.\n38 CFR 3.320a\ndisability\nN/A\nJanuary 2, 2025, the date the regulation went into effect to allow for presumptive SC.\n38 CFR 3.320b\ndisability\nN/A\nJanuary 10, 2025, the date the regulation went into effect to allow for presumptive SC.\nNote\n:  If warranted by the facts of the case, award retroactive benefits under\n38 CFR 3.114(a)\n.\nReference\n:  For more information on assigning effective dates, see\n38 CFR 3.400\n38 CFR 3.114\n, and\n38 CFR 3.156(c)\n.\n2\n.\nDenying SC for Disabilities Associated With BPOT Exposure\nIntroduction\nThis topic contains information about denying SC for disabilities associated with BPOT exposure, including\nwhen presumptive SC cannot be established\n, and\nrequirement to provide adequate explanation of decisions to deny\n.\nChange Date\nDecember 7, 2023\nVIII.ii.2.C.2.a\n.\nWhen Presumptive SC Cannot Be Established\nAs discussed in\nM21-1, Part VIII, Subpart ii, 2.A.1.d\n, SC cannot be established on a presumptive basis if\nthe Veteran\ndid not serve in a qualifying location as listed in\nM21-1, Part VIII, Subpart ii, 2.A.1.e\n, or\nis not diagnosed with a presumptive BPOT\ndisability\nthere is affirmative evidence that the BPOT\ndisability\nwas caused by another condition or event that occurred between the Veteran’s qualifying service and the onset of the disability, or\nwas the result of the Veteran’s own willful misconduct or the abuse of alcohol or drugs.\nReference\n:  For more information on establishing SC under\n38 U.S.C. 1120\n, see\nM21-1, Part VIII, Subpart ii, 2.A\n, and\nVBA Letter 20-24-06\n.\nVIII.ii.2.C.2.b\n.\nRequirement to Provide Adequate Explanation of Decisions to Deny\nWhen denying SC for a condition based on BPOT exposure, the decision and decision notice must provide adequate reasons for the decision.  Decision makers must include a discussion of the specific provisions that were not met under the relevant presumptive provisions, as well as any other avenue of SC raised by the claimant or evidence.\nIn order to properly document decisions to deny benefits based on BPOT exposure in VBMS-R, claims processors must:\nuse a combination of any applicable system-generated language, glossary text fragments, and free text to ensure the decision and decision notice adequately explain why the claim could not be granted under all applicable provisions, and\napply the appropriate special issue and special issue basis for each decided contention.\nImportant\n:  If the system-generated text options do not adequately cover the reason a claim is being denied, decision makers must use glossary text or free text to supplement the explanation of the decision.\nReferences\n:  For more information on\nBPOT general rating decision requirements, see\nM21-1, Part VIII, Subpart ii, 2.C.1.d\nsystem-generated text and glossary fragments, see the\nVBMS Rating User Guide\nconsidering unclaimed theories of SC, see\nM21-1, Part II, Subpart iii, 1.A.2.e\n, and\ndecision notification requirements, see\n38 CFR 3.103(f)\n.\n3\n.\nAdditional Rating Considerations\nChange Date\nDecember 7, 2023\nVIII.ii.2.C.3.a\n.\nSpecial Provisions Regarding the Evaluation of Respiratory Conditions\nThe rating activity must consider the provisions of\n38 CFR 4.96\nwhen granting entitlement to SC for certain respiratory disabilities.  These provisions include\nprohibitions for separately evaluating certain coexisting respiratory conditions\nentitlement to special monthly compensation in specific cases, and\nrequirements for pulmonary function tests.\nReference\n:  For more information on evaluating respiratory disabilities, see\n38 CFR 4.97\n, and\nM21-1, Part V, Subpart iii, 4.A\n.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000177442\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section B - Developing Claims Based On Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177442/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-B-Developing-Claims-Based-On-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">&lt;-- Previous Section</a>   <a articleid=\"554400000177449\" articlename=\"M21-1, Part VIII, Subpart iii, Chapter 1 - Service Connection (SC) for Tropical Diseases\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177449/M21-1-Part-VIII-Subpart-iii-Chapter-1-Service-Connection-SC-for-Tropical-Diseases\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This section contains the following topics: </span></span></div><div></div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"height: 0px; width: 495px; border-spacing: 0px; border-collapse: revert;\" width=\"495\"><tbody><tr><td style=\"width: 87px; padding: 0px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong>Topic</strong></span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong>Topic Name</strong></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1\" target=\"_self\">Presumptive Service Connection (SC) for Disabilities Associated With BPOT Exposure</a></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">2</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2\" target=\"_self\">Denying SC for Disabilities Associated With BPOT Exposure </a></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">3</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#3\" target=\"_self\">Additional Rating Considerations</a></span></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><p></p><p></p></div><h2 class=\"ng-scope\"> <span style=\"font-size: 16px\"><span style=\"font-family: arial, helvetica, sans-serif\">1<a id=\"1\" name=\"1\">.</a>  Presumptive SC for Disabilities Associated With BPOT Exposure </span></span></h2><p class=\"ng-scope\"></p><p class=\"ng-scope\"></p><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic contains information about presumptive SC for disabilities associated with BPOT exposure, including</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\">establishing SC for a qualifying presumptive disability</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1b\" target=\"_self\">date disabilities became subject to presumptive SC based on BPOT exposure</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1c\" target=\"_self\">presumptive SC for asthma</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1d\" target=\"_self\">BPOT general rating decision requirements</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1e\" target=\"_self\">establishing an effective date for qualifying disabilities due to BPOT exposure</a>.</span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">June 6, 2025</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.ii.2.C.1.a<a id=\"1a\" name=\"1a\">.</a>  Establishing SC for a Qualifying Presumptive Disability </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Establish presumptive service connection (SC) due to fine particulate matter exposure if the evidence establishes </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">service in a qualifying location as described in <a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">M21-1, Part VIII, Subpart ii, 2.A.1.e</a>, and </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the Veteran has been diagnosed with a condition listed in </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a></span></span></span></span></div></li><li><div><span style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320a\" target=\"_blank\">38 CFR 3.320a</a>, or</span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320b\" target=\"_blank\">38 CFR 3.320b</a>.</span></span></span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b>:  </span></span></span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Presumptive SC for the conditions listed in <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a> became effective August 10, 2022, based on <i>Public Law 117-168</i>, Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act of 2022.</span></span></span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Under current rules, the presumption of SC does not require the disability to manifest within any time frame after service nor to any degree of disability.</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Presumptive SC for cancer associated with exposure to burn pits and other toxins, including fine particulate matter (BPOT) may only be established if the cancer in consideration is the primary or originating site of the cancer.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on</span></span></span></span></div><a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\"> </a><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the history of BPOT exposure policies, see <a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">M21-1, Part VIII, Subpart ii, 2.A.1.a</a></span></span> </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">which diagnoses qualify as a presumptive under <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a>, see</span></span> </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\" target=\"_blank\"><i>VBA Letter 20-24-06, Updated Guidance on Processing Claims Involving PACT Act</i></a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">M21-1, Part VIII, Subpart ii, 2.A.1.f</a></span></span></div></li></ul></li><li><div><span style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\">presumptive SC for metastatic cancer, see <a articleid=\"554400000180482\" articlename=\"M21-1, Part V, Subpart ii, Chapter 2, Section B - Presumptive Service Connection (SC)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180482/M21-1-Part-V-Subpart-ii-Chapter-2-Section-B-Presumptive-Service-Connection-SC\">M21-1, Part V, Subpart ii, 2.B.1.b</a>, and</span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">presumptive BPOT disabilities, see <a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">M21-1, Part VIII, Subpart ii, 2.A.1.f-h<!--?a-->.</a></span></span></li></ul><a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\"> </a></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VIII.ii.2.C.1.b<a id=\"1b\" name=\"1b\">.</a>  Date Disabilities Became Subject to Presumptive SC Based on BPOT Exposure</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">The table below shows the dates on which the BPOT disabilities became subject to presumptive SC.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a two column table.  Column 1 lists the disabilities and column 2 shows the effective date on which the disabilities became subject to presumptive SC.\" width=\"510\"><thead><tr><th style=\"width: 375px; padding: 1px;\"><div align=\"center\" style=\"text-align: center;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b>Disability</b></span></span></div></th><th style=\"width: 135px; padding: 1px;\"><div align=\"center\" style=\"text-align: center;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b>Effective Date</b></span></span></div></th></tr></thead><tbody><tr><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Chronic respiratory illnesses:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">asthma</span></span></li><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">rhinitis, and</span></span></li><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">sinusitis, to include rhinosinusitis.</span></span></li></ul><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Important</i></b>:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Under historical 38 CFR 3.320, these conditions were required to have manifested within 10 years of separation from a period of active duty.</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Historical 38 CFR 3.320 was superseded by the PACT Act on August 10, 2022.</span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">August 5, 2021</span></span></div></td></tr><tr><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Specific rare respiratory cancers:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">squamous cell carcinoma (SCC) of the larynx</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">SCC of the trachea</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">adenocarcinoma of the trachea</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">salivary gland-type tumors of the trachea</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">adenosquamous carcinoma of the lung</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">large cell carcinoma of the lung</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">salivary gland-type tumors of the lung</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">sarcomatoid carcinoma of the lung, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">typical and atypical carcinoid of the lung.</span></span></div></li></ul><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Important</i></b>:  This historical provision in 38 CFR 3.320 was superseded by the PACT Act on August 10, 2022.</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">April 26, 2022</span></span></div></td></tr><tr><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Disabilities listed in <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a>:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">head cancer of any type</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">neck cancer of any type</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">respiratory cancer of any type</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">gastrointestinal cancer of any type</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">reproductive cancer of any type</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">lymphoma cancer of any type</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">kidney cancer</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">brain cancer</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">melanoma</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">pancreatic cancer</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">chronic bronchitis</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">chronic obstructive pulmonary disease</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">constrictive bronchiolitis or obliterative bronchiolitis</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">emphysema</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">granulomatous disease</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">interstitial lung disease</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">pleuritis</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">pulmonary fibrosis</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">sarcoidosis</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">glioblastoma</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">asthma diagnosed after service</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">chronic sinusitis, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">chronic rhinitis.</span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">August 10, 2022</span></span></div></td></tr><tr><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320a\" target=\"_blank\">38 CFR 3.320a</a>:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">urinary bladder cancer, including over-lapping sites of the bladder, and</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">ureter cancer, including the ureteric orifice, and urachus.</span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">January 2, 2025</span></span></div></td></tr><tr><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320b\" target=\"_blank\">38 CFR 3.320b</a>:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">acute leukemias</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">chronic leukemias</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">multiple myelomas, including monoclonal gammopathy of undetermined significance</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">myelodysplastic syndromes, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">myelofibrosis.</span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">January 10, 2025</span></span></div></td></tr></tbody></table><div> <span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">    </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VIII.ii.2.C.1.c<a id=\"1c\" name=\"1c\">.</a>  Presumptive SC for Asthma</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">The PACT Act provided for presumptive SC for, “asthma that was diagnosed after service of the covered Veteran.”  This means the presumption only applies when asthma is diagnosed after service.  Asthma is also a presumptive condition presumed to be associated with exposure to fine particulate matter per <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320\" target=\"_blank\">38 CFR 3.320</a>.  </span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">The Department of Veterans Affairs has implemented the PACT Act presumption for asthma as shown in the table below for all decisions made.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" width=\"510\"><thead><tr><th style=\"padding: 1px;\"><div style=\"text-align: left;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b>If asthma was first diagnosed …</b></span></span></div></th><th style=\"padding: 1px;\"><div style=\"text-align: left;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b>Then …</b></span></span></div></th></tr></thead><tbody><tr><td style=\"padding: 1px;\"><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">prior to, or</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">during service</span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">SC must be considered under other theories of entitlement (i.e., direct, aggravation).</span></span></div></td></tr><tr><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">after service</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">the presumption of SC under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320\" target=\"_blank\">38 CFR 3.320</a> and <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a> applies.</span></span></div></td></tr></tbody></table><div><span style=\"font-family:Arial,Helvetica,sans-serif;\"><span style=\"font-size:14px;\">  </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VIII.ii.2.C.1.d<a id=\"1d\" name=\"1d\">.</a>  BPOT General Rating Decision Requirements</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">In order to properly document decisions based on BPOT exposure in Veterans Benefits Management System-Rating (VBMS-R), claims processors must use a combination of applicable system-generated language, analysis fragments, and glossary text fragments to adequately explain the basis of all decisions.</span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"> </span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">If awarding or denying a claim for presumptive SC based on BPOT exposure, apply the following guidelines:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">cite the applicable regulatory or statutory authority for the decision, when applicable</span></span></li><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">list favorable findings, if applicable, specific to the facts of the case, and</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">assign the appropriate special issue and special issue basis to each decided issue.</span></span></div></li></ul></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><em><strong>References</strong></em>:  For more information on </span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">completing the rating decision, see</span></span></div></li><li><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a articleid=\"554400000180523\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section A - Completing the Rating Decision Narrative\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180523/M21-1-Part-V-Subpart-iv-Chapter-1-Section-A-Completing-the-Rating-Decision-Narrative\">M21-1, Part V, Subpart iv, 1.A</a>, and </span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">the <em>VBMS Rating User Guide</em>, and</span></span></div></li></ul></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">historical rating requirements for particulate matter claims, see the attachment, <em>Historical_M21-1VIII_ii_2_SecC_5-4-22.docx.</em></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VIII.ii.2.C.1.e<a id=\"1e\" name=\"1e\">.</a>  Establishing an Effective Date for Disabilities Due to BPOT Exposure</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">When assigning an effective date, follow the guidance in <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A</a> relevant to the facts of the claim.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">In addition to the general principles governing the assignment of effective dates, consider the following relevant factors when awarding presumptive SC based on BPOT exposure:</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">When did the disability become subject to presumptive SC?</span></span></li><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Did the Veteran’s service qualify under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=9f0ce8e46464a943446b3eabce7d0edb&amp;node=se38.1.3_1317&amp;rgn=div8\" target=\"_blank\">38 CFR 3.320</a> or under a location added in <a href=\"https://www.law.cornell.edu/uscode/text/38/1119\" target=\"_blank\">38 U.S.C. 1119</a>?</span></span></li><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Did the qualifying disability manifest within any applicable manifestation period?</span></span></li></ul><div><span style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\">Use the table below when assigning an effective date based on presumptive BPOT SC requirements being met.</span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"This is an if-and-then table.  Columns 1 and 2 contain the conditions and column 3 contains information on the effective date.\" width=\"573\"><thead><tr><th style=\"padding: 1px;\"><div style=\"text-align: left;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b>If the award involves a …</b></span></span></div></th><th style=\"padding: 1px;\"><div style=\"text-align: left;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b>And the condition …</b></span></span></div></th><th style=\"padding: 1px;\"><div style=\"text-align: left;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b>Then the effective date cannot be prior to</b> <b>…</b></span></span></div></th></tr></thead><tbody><tr><td rowspan=\"2\" style=\"vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">current <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320\" target=\"_blank\">38 CFR 3.320(a)(2)</a> condition (sinusitis, rhinitis, or asthma), and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320\" target=\"_blank\">38 CFR 3.320</a> location</span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">manifested outside the 10-year manifestation period</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">August 10, 2022, the date the law was changed to allow for the award of benefits under <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a>.</span></span></div></td></tr><tr><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">manifested within the 10-year manifestation period</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">August 5, 2021, the date the regulation went into effect to allow for presumptive SC.</span></span></div></td></tr><tr><td style=\"vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">historical 38 CFR 3.320(a)(3) condition (rare respiratory cancer), and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320\" target=\"_blank\">38 CFR 3.320</a> location</span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">N/A</span></span></div></td><td style=\"vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">April 26, 2022, the date the regulation went into effect to allow for presumptive SC.</span></span></div></td></tr><tr><td style=\"vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">location added in <a href=\"https://www.law.cornell.edu/uscode/text/38/1119\" target=\"_blank\">38 U.S.C. 1119</a>, or</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">presumptive condition added by <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a></span></span></div></li></ul></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">N/A</span></span></div></td><td style=\"vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">August 10, 2022, the date the law was changed to allow for the award of benefits under <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a>.</span></span></div></td></tr><tr><td style=\"vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320a\" target=\"_blank\">38 CFR 3.320a</a> disability</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">N/A</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">January 2, 2025, the date the regulation went into effect to allow for presumptive SC.</span></span></div></td></tr><tr><td style=\"vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320b\" target=\"_blank\">38 CFR 3.320b</a> disability</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">N/A</span></span></div></td><td style=\"padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">January 10, 2025, the date the regulation went into effect to allow for presumptive SC.</span></span></div></td></tr></tbody></table><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Note</i></b>:  If warranted by the facts of the case, award retroactive benefits under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.114\" target=\"_blank\">38 CFR 3.114(a)</a>.</span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i> </i></b></span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Reference</i></b>:  For more information on assigning effective dates, see</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR429f47d98271c40/section-3.400\" target=\"_blank\">38 CFR 3.400</a></span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.114\" target=\"_blank\">38 CFR 3.114</a>, and</span></span></div></li><li><div><span style=\"font-size:12pt\"><span style='font-family:\"Times New Roman\", serif'><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR7629a1b1e9bf6f8/section-3.156\" target=\"_blank\">38 CFR 3.156(c)</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\"></div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">2<a id=\"2\" name=\"2\">.</a>  Denying SC for Disabilities Associated With BPOT Exposure</span></span></h2><p class=\"ng-scope\"></p><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic contains information about denying SC for disabilities associated with BPOT exposure, including </span></span></div><ul><li class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">when presumptive SC cannot be established</a>, and</span></span></li><li class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"color: black\"><a href=\"#2b\" target=\"_self\">requirement to provide adequate explanation of decisions to deny</a>.</span></span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">December 7, 2023</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.ii.2.C.2.a<a id=\"2a\" name=\"2a\">.</a>  When Presumptive SC Cannot Be Established</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">As discussed in <a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">M21-1, Part VIII, Subpart ii, 2.A.1.d</a>, SC cannot be established on a presumptive basis if </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the Veteran</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">did not serve in a qualifying location as listed in <a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">M21-1, Part VIII, Subpart ii, 2.A.1.e</a>, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"color: black\">is not diagnosed with a presumptive BPOT </span>disability </span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">there is affirmative evidence that the BPOT</span> disability</span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">was caused by another condition or event that occurred between the Veteran’s qualifying service and the onset of the disability, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">was the result of the Veteran’s own willful misconduct or the abuse of alcohol or drugs.</span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on establishing SC under <a href=\"https://www.law.cornell.edu/uscode/text/38/1120\" target=\"_blank\">38 U.S.C. 1120</a>, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000177441\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section A - General Information on Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177441/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-A-General-Information-on-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">M21-1, Part VIII, Subpart ii, 2.A</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\" target=\"_blank\"><i>VBA Letter 20-24-06</i></a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.ii.2.C.2.b<a id=\"2b\" name=\"2b\">.</a>  Requirement to Provide Adequate Explanation of Decisions to Deny</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">When denying SC for a condition based on BPOT exposure, the decision and decision notice must provide adequate reasons for the decision.  Decision makers must include a discussion of the specific provisions that were not met under the relevant presumptive provisions, as well as any other avenue of SC raised by the claimant or evidence.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">In order to properly document decisions to deny benefits based on BPOT exposure in VBMS-R, claims processors must:</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">use a combination of any applicable system-generated language, glossary text fragments, and free text to ensure the decision and decision notice adequately explain why the claim could not be granted under all applicable provisions, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">apply the appropriate special issue and special issue basis for each decided contention.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b></span>:  If the system-generated text options do not adequately cover the reason a claim is being denied, decision makers must use glossary text or free text to supplement the explanation of the decision.</span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b></span><span style=\"color: black\">:  For more information on </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">BPOT general rating decision requirements, see <a href=\"#1d\" target=\"_self\">M21-1, Part VIII, Subpart ii, 2.C.1.d</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"color: black\">system-generated text and glossary fragments, see the <i>VBMS Rating User Guide</i></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">considering unclaimed theories of SC, see <a articleid=\"554400000174869\" articlename=\"M21-1, Part II, Subpart iii, Chapter 1, Section A - Applications for Benefits\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174869/M21-1-Part-II-Subpart-iii-Chapter-1-Section-A-Applications-for-Benefits\">M21-1, Part II, Subpart iii, 1.A.2.e</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">decision notification requirements, see <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.103\" target=\"_blank\">38 CFR 3.103(f)</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\"></div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">3<a id=\"3\" name=\"3\">.</a>  Additional Rating Considerations</span></span></h2><p class=\"ng-scope\"></p><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">December 7, 2023</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.ii.2.C.3.a<a id=\"3a\" name=\"3a\">.</a>  Special Provisions Regarding the Evaluation of Respiratory Conditions</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The rating activity must consider the provisions of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=a88986ca8f9a29e8af73cdffa7bc08f9&amp;node=se38.1.4_196&amp;rgn=div8\" target=\"_blank\">38 CFR 4.96</a> when granting entitlement to SC for certain respiratory disabilities.  These provisions include </span></span></div><div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">prohibitions for separately evaluating certain coexisting respiratory conditions</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">entitlement to special monthly compensation in specific cases, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">requirements for pulmonary function tests.</span></span></li></ul></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i><span style=\"color: black\">Reference</span></i></b><span style=\"color: black\">:  For more information on evaluating respiratory disabilities, see </span></span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-4/subpart-B/subject-group-ECFR14fb86bcc86c2cb/section-4.97\" target=\"_blank\">38 CFR 4.97</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000180967\" articlename=\"M21-1, Part V, Subpart iii, Chapter 4, Section A - Respiratory Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180967/M21-1-Part-V-Subpart-iii-Chapter-4-Section-A-Respiratory-Conditions\">M21-1, Part V, Subpart iii, 4.A</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000177442\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 2, Section B - Developing Claims Based On Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177442/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-B-Developing-Claims-Based-On-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT\">&lt;-- Previous Section</a>   <a articleid=\"554400000177449\" articlename=\"M21-1, Part VIII, Subpart iii, Chapter 1 - Service Connection (SC) for Tropical Diseases\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177449/M21-1-Part-VIII-Subpart-iii-Chapter-1-Service-Connection-SC-for-Tropical-Diseases\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\" style=\"text-align: left\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 11px\"><a href=\"#top\" target=\"_self\">To Top</a></span></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=9f0ce8e46464a943446b3eabce7d0edb&node=se38.1.3_1317&rgn=div8",
    "https://vbaw.vba.va.gov/bl/21/pact.htm",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=a88986ca8f9a29e8af73cdffa7bc08f9&node=se38.1.4_196&rgn=div8",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320a",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.320b",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR429f47d98271c40/section-3.400",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.103",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.114",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR7629a1b1e9bf6f8/section-3.156",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-4/subpart-B/subject-group-ECFR14fb86bcc86c2cb/section-4.97",
    "https://www.law.cornell.edu/uscode/text/38/1119",
    "https://www.law.cornell.edu/uscode/text/38/1120"
  ],
  "scraped_at": "2025-06-16T22:57:23.049292",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177449/M21-1-Part-VIII-Subpart-iii-Chapter-1-Service-Connection-SC-for-Tropical-Diseases"
}